Health

  • April 22, 2026

    Florida Co. Accused Of $91M Fake Obamacare Scheme

    The Federal Trade Commission accused a Florida company and its executives of operating a nationwide scheme selling fake Obamacare plans, alleging in a federal lawsuit unsealed Wednesday that they made at least $91 million by tricking people into purchasing fraudulent health benefits packages.

  • April 22, 2026

    Chicago-Area Jury Awards $7.25M In Hysterectomy Suit

    A Chicago-area jury has hit five University of Illinois Hospital doctors and a nurse with a $7.25 million verdict over claims they botched a delivery and cesarean section, leaving a 32-year-old woman permanently unable to give birth to any more children.

  • April 22, 2026

    Feds Must Give Records On Trans Military Ban, Judge Says

    A Washington federal court has ordered the Trump administration to produce records underlying its decision to bar transgender individuals from serving in the U.S. military, rejecting a distinction the administration carved between trans individuals and individuals with gender dysphoria.

  • April 22, 2026

    Health System Says AI Co. Botched $32M Software Project

    A San Francisco-based healthcare technology company failed to deliver on promises it would consolidate a Catholic health system's data under a unified platform, breaching a projected $32 million service agreement, the health system alleged in a complaint.

  • April 22, 2026

    Consolidation Recommended For NY Hospital Antitrust Cases

    Two antitrust lawsuits accusing New York-Presbyterian Hospital of using anticompetitive tactics when negotiating with insurers should move forward as one, a New York magistrate judge said Wednesday, encouraging a federal district judge to consolidate the proposed class actions filed by a pair of union benefit funds.

  • April 22, 2026

    Bayer 'Natural' Vitamin Buyer Classes Affirmed By 9th Circ.

    A split Ninth Circuit on Tuesday upheld a federal district court's certification of New York and California classes of consumers who bought Bayer Healthcare multivitamin gummies that were allegedly labeled falsely as "natural," finding the company "demands more" from the plaintiffs at this stage of the litigation than certification requires. 

  • April 22, 2026

    Workers' Attys Get $940K As $4.7M Tobacco Deal Approved

    A Virginia federal judge on Wednesday awarded $940,000 in attorney fees to class counsel who secured a $4.7 million settlement with food distributor Performance Food Group over claims that it unlawfully charged tobacco users an extra fee for health benefits.

  • April 22, 2026

    Eli Lilly Case Over Weight Loss Drugs Kept Mostly Intact

    A California federal court has refused to throw out a lawsuit from Eli Lilly against a telehealth company and related entities over the compounding of its popular weight loss drugs Mounjaro and Zepbound, but agreed to trim a conspiracy claim from the case.

  • April 22, 2026

    Justices Would Back Vax Law Challenge, 2nd Circ. Told

    The U.S. Supreme Court's March 2 decision in a California gender-related school policy case requires the Second Circuit to advance a 2023 challenge to Connecticut's preschool and daycare student vaccine mandates, an attorney for a Constitution State congregation told a three-judge panel on Wednesday.

  • April 22, 2026

    5th Circ. Bars Dead Veteran's VA Surgery Suit As Untimely

    The estate of a dead veteran who filed a medical malpractice lawsuit 18 years after an unauthorized operation at a Veterans Affairs hospital didn't bring the suit within Mississippi's seven-year deadline for medical malpractice claims, the Fifth Circuit ruled Wednesday.

  • April 22, 2026

    Judge Lets Pharma Co. Seal Parts Of Ex-GC's Retaliation Suit

    A Texas state judge on Wednesday granted Houston-based Empower Clinic Services LLC's bid to permanently and partially seal a petition by its former general counsel that alleges a smear campaign by the company after he confronted them about conduct he said was unlawful.

  • April 22, 2026

    Sorrento, M3 Get Pause On RICO Suit Naming Jackson Walker

    A Texas bankruptcy judge on Wednesday agreed to put on hold a lawsuit in California federal court alleging Jackson Walker LLP and executives at Sorrento Therapeutics and M3 Partners conspired to forum shop in Texas so the drug developer could seek Chapter 11 protection there.

  • April 22, 2026

    Simpson Thacher Adds Another Kirkland Finance Alum In Calif.

    Simpson Thacher & Bartlett LLP has hired another former Kirkland & Ellis LLP partner to join its recently formed capital structure solutions practice in the San Francisco area, where she'll focus on banking and other finance matters, Simpson Thacher announced Wednesday.

  • April 22, 2026

    Commure Took Health Co.'s Software Trade Secrets, Suit Says

    A San Diego-based healthcare technology services company has accused Commure Inc. of stealing trade secrets to launch competing cloud-based software, framing the alleged conduct as an instance of a large company "backed by big money" breaking the rules to obtain a much smaller competitor's information.

  • April 22, 2026

    Ex-Conn. Prosecutor Fights Drug Co. Bid To Appeal DQ Denial

    Insurers Humana Inc. and Molina Healthcare Inc. urged a federal judge to turn down a group of generic-drug makers' request for an immediate trip to the Third Circuit, arguing the drugmakers' bid for a second chance to disqualify Connecticut's former assistant attorney general from an antitrust case was not qualified for an interlocutory appeal.

  • April 22, 2026

    Kirkland Keeps Growing In Philly With Private Equity Atty

    Kirkland & Ellis LLP announced Wednesday it is continuing to expand its new Philadelphia office with the recent addition of a private equity attorney, who has moved his practice after more than 12 years with Morgan Lewis & Bockius LLP.

  • April 22, 2026

    4 Firms Build Amneal's Up To $1.1B Kashiv Biosimilars Buy

    Biopharmaceutical company Amneal Pharmaceuticals Inc. on Wednesday unveiled plans to acquire biosimilars-focused Kashiv BioSciences LLC in a deal worth up to $1.1 billion that was built by four law firms.

  • April 22, 2026

    Life Policy With $21M Payout Voided As Illegal Life Wager

    A Delaware federal court voided a life insurance policy as an unlawful wager on a now-deceased Florida woman's life, finding that Ameritas Life Insurance Corp. is entitled to retain the policy's $10 million death benefit and $11 million in premium payments.

  • April 22, 2026

    Healthcare REIT Raises $462M In IPO Advised By 4 Firms

    Healthcare-focused real estate investment trust National Healthcare Properties began trading Wednesday after raising $462 million in an initial public offering guided by Paul Weiss, Greenberg Traurig LLP, Sidley Austin LLP and Venable LLP.

  • April 21, 2026

    Nourish Can't Ax Wiretap Claims In Google Data Sharing Row

    An Illinois federal judge has refused to cut wiretap and negligence claims from a proposed class action accusing telehealth provider Nourish Inc. of deploying tracking tools that illegally transmitted website visitors' sensitive health information to Google, while tossing several privacy and contract allegations and rebuking the plaintiffs for filing a "press release complaint."

  • April 21, 2026

    Georgia Panel Tosses $123K Fee Award After Defense Win

    A Georgia appellate panel tossed on Tuesday an award of $123,000 in attorney fees to defense counsel after their win in a medical malpractice trial, ruling that a state judge failed to show how she arrived at the figure.

  • April 21, 2026

    Congress Rallies More For Bills On Copyrights Than Patents

    There have been more intellectual property bills floated in Congress that are supportive of copyright rights than patent rights, according to a new report looking at how lawmakers treat the IP system.

  • April 21, 2026

    Amgen Faces ERISA Suit Over Health Plan Tobacco Surcharge

    A former Amgen Inc. employee filed a proposed class action in California federal court Tuesday alleging the biotech company discriminatorily imposes an "egregiously high" $150-a-month surcharge on employees who use tobacco products, while failing to adequately notify them of reasonable pathways to avoid the fees, in violation of federal benefits law.

  • April 21, 2026

    ProMedica Wins Bid To Unseal Gov't Probe Briefs In FCA Suit

    Nursing home operator ProMedica Health Systems Inc. has succeeded in its bid to unseal government briefs in a whistleblower case over alleged problems caused by understaffing at its facilities, with a Pennsylvania federal judge ruling that a presumption of openness with court records trumped the government's concerns about disclosure of its investigative methods.

  • April 21, 2026

    Watchdog Says Ex-Fla. Rep Used Straw Donors For Campaign

    A Washington, D.C.-based watchdog organization accused former Florida Rep. Sheila Cherfilus-McCormick of improperly funding her 2022 reelection bid to the U.S. House of Representatives, saying she orchestrated a complex straw donor scheme to funnel $725,000 in Haitian "dark money" into her campaign. 

Expert Analysis

  • 5 E-Discovery Predictions For 2026 And Beyond

    Author Photo

    2026 will likely be shaped by issues ranging from artificial intelligence regulatory turbulence to potential evidence rule changes, and e-discovery professionals will need to understand how to effectively guide the responsible and defensible adoption of emerging tools, while also ensuring effective safeguards, say attorneys at Littler.

  • 2026 State AI Bills That Could Expand Liability, Insurance Risk

    Author Photo

    State bills legislating artificial intelligence that are expected to pass in 2026 will reshape the liability landscape for all companies incorporating AI solutions into their business operations, as any novel private rights of action authorized under AI-related statutes signal expanding exposures, say attorneys at Wiley.

  • Business Considerations Amid Hemp Product Policy Change

    Author Photo

    With the passage of a bill fundamentally narrowing the federal definition of "hemp," there are practical and business considerations that brands, manufacturers and other parties should heed over the next year, including operational strategies, evaluating contract and counterparty risk, and tax implications, say attorneys at Foley Hoag.

  • Series

    Judges On AI: How Courts Can Boost Access To Justice

    Author Photo

    Arizona Court of Appeals Judge Samuel A. Thumma writes that generative artificial intelligence tools offer a profound opportunity to enhance access to justice and engender public confidence in courts’ use of technology, and judges can seize this opportunity in five key ways.

  • Opinion

    DHS' Parole Termination Violates APA And Due Process

    Author Photo

    The U.S. Department of Homeland Security’s abrupt termination of family reunification parole programs violates both the Administrative Procedure Act and the due process rights of vetted beneficiaries who relied on the government's explicit invitation to wait in the U.S. for an immigrant visa to become available, says Abdoul Konare at Konare Law.

  • 2025's Most Notable State AG Activity By The Numbers

    Author Photo

    State attorneys general were active in 2025, working across party lines to address federal regulatory gaps in artificial intelligence, take action on consumer protection issues, continue antitrust enforcement and announce large settlements on behalf of their citizens, say attorneys at Jenner & Block.

  • Opinion

    The Case For Emulating, Not Dividing, The Ninth Circuit

    Author Photo

    Champions for improved judicial administration should reject the unfounded criticisms driving recent Senate proposals to divide the Ninth Circuit and instead seek to replicate the court's unique strengths and successes, says Ninth Circuit Judge J. Clifford Wallace.

  • How 11th Circ.'s Zafirov Decision Could Upend Qui Tam Cases

    Author Photo

    Oral argument before the Eleventh Circuit last month in U.S. ex rel. Zafirov v. Florida Medical Associates suggests that the court may affirm a lower court's opinion that the qui tam provisions of the False Claims Act are unconstitutional — which could wreak havoc on pending and future qui tam cases, say attorneys at Morgan Lewis.

  • Key Trends For Life Sciences Cos. To Watch In 2026

    Author Photo

    Following a year of drastic change at the U.S. Food and Drug Administration, two themes are likely to drive the coming year — a commitment to lowering the cost of drugs and an inherent tension between the priorities of the health agencies and the broader administration, say attorneys at Sheppard Mullin.

  • Series

    Muay Thai Makes Me A Better Lawyer

    Author Photo

    Muay Thai kickboxing has taught me that in order to win, one must stick to one's game plan and adapt under pressure, just as when facing challenges by opposing counsel or judges, says Mark Schork at Feldman Shepherd.

  • The Next Pressure Point In Digital Health: Informed Consent

    Author Photo

    Two new federal digital health initiatives will usher in a new era where virtual care, software-enabled devices and home-based monitoring are integrated into care and reimbursement models, with the impact of shifting rules and opportunities felt most immediately in the context of informed consent, says Kimberly Chew at Husch Blackwell.

  • Series

    Law School's Missed Lessons: Intentional Career-Building

    Author Photo

    A successful legal career is built through intention: understanding expectations, assessing strengths honestly and proactively seeking opportunities to grow and cultivating relationships that support your development, say Erika Drous and Hillary Mann at Morrison Foerster.

  • 4 Trends Shaping Drug And Medical Device Law For 2026

    Author Photo

    2025 saw some significant legal developments with potential impact for drug and device manufacturers, ranging from growing skepticism in science and regulatory entities to new regulation of artificial intelligence, say attorneys at Faegre Drinker.

  • Key Trends In Healthcare Antitrust In 2025

    Author Photo

    The healthcare industry braced for significant antitrust enforcement shifts last year driven by a change in administration, and understanding the implications of these trends is critical for healthcare organizations' risk management and strategic decision-making in the year ahead, say attorneys at Michael Best.

  • The 5 Most Important Bid Protest Decisions Of 2025

    Author Photo

    In a shifting bid protest landscape, five decisions in 2025 from the Federal Circuit, the U.S. Court of Federal Claims and the U.S. Government Accountability Office that addressed bedrock questions about jurisdictional reach and the breadth of agency discretion are likely to have a lasting impact, say attorneys at Bradley Arant.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Health archive.